blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News flashes

New version of the European Patent Register - SPC information for Unitary Patents.

2024-03-06

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3183359

EP3183359 - EFFICIENT SELECTIVITY OF RECOMBINANT PROTEINS [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  22.10.2021
Database last updated on 26.06.2024
FormerThe patent has been granted
Status updated on  13.11.2020
FormerGrant of patent is intended
Status updated on  16.08.2020
FormerExamination is in progress
Status updated on  30.09.2019
FormerRequest for examination was made
Status updated on  26.05.2017
FormerThe international publication has been made
Status updated on  22.02.2017
Most recent event   Tooltip22.10.2021No opposition filed within time limitpublished on 24.11.2021  [2021/47]
Applicant(s)For all designated states
Regeneron Pharmaceuticals, Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
[2017/26]
Inventor(s)01 / DESHPANDE, Dipali
c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
02 / BURAKOV, Darya
c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
03 / CHEN, Gang
c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
04 / FANDL, James
c/o Regeneron Pharmaceuticals Inc.
777 Old Saw Mill River Road
Tarrytown, NY 10591 / US
 [2017/26]
Representative(s)J A Kemp LLP
80 Turnmill Street
London EC1M 5QU / GB
[N/P]
Former [2020/51]J A Kemp LLP
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Former [2017/26]Aston, Heidi Frances
J A Kemp
14 South Square
Gray's Inn
London WC1R 5JJ / GB
Application number, filing date15833421.919.08.2015
[2017/26]
WO2015US45793
Priority number, dateUS201462039416P19.08.2014         Original published format: US 201462039416 P
[2017/26]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2016028838
Date:25.02.2016
Language:EN
[2016/08]
Type: A1 Application with search report 
No.:EP3183359
Date:28.06.2017
Language:EN
The application published by WIPO in one of the EPO official languages on 25.02.2016 takes the place of the publication of the European patent application.
[2017/26]
Type: B1 Patent specification 
No.:EP3183359
Date:16.12.2020
Language:EN
[2020/51]
Search report(s)International search report - published on:US25.02.2016
(Supplementary) European search report - dispatched on:EP02.03.2018
ClassificationIPC:C12P21/06, C12N15/00, C12P21/00, C12N15/85
[2018/13]
CPC:
C12P21/005 (EP,EA,IL,KR,US); C07K16/00 (IL,KR); C12N15/85 (EA,IL,KR,US);
C07K2319/30 (EP,EA,IL,KR,US); C12N2510/02 (IL,KR); C12N2840/203 (IL,KR)
Former IPC [2017/26]C12P21/06, C12N15/00, C12N5/07, C12N5/10, C12N5/02, C12N9/12
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2017/26]
Extension statesBA20.02.2017
ME20.02.2017
Validation statesMA20.02.2017
TitleGerman:EFFIZIENTE SELEKTIVITÄT REKOMBINANTER PROTEINE[2017/26]
English:EFFICIENT SELECTIVITY OF RECOMBINANT PROTEINS[2017/26]
French:SÉLECTIVITÉ EFFICACE DES PROTÉINES RECOMBINÉES[2017/26]
Entry into regional phase20.02.2017National basic fee paid 
20.02.2017Search fee paid 
20.02.2017Designation fee(s) paid 
20.02.2017Examination fee paid 
Examination procedure15.06.2016Request for preliminary examination filed
International Preliminary Examining Authority: US
20.02.2017Examination requested  [2017/26]
20.02.2017Date on which the examining division has become responsible
28.09.2018Amendment by applicant (claims and/or description)
04.10.2019Despatch of a communication from the examining division (Time limit: M04)
05.02.2020Reply to a communication from the examining division
17.03.2020Despatch of a communication from the examining division (Time limit: M04)
21.05.2020Reply to a communication from the examining division
17.08.2020Communication of intention to grant the patent
06.11.2020Fee for grant paid
06.11.2020Fee for publishing/printing paid
06.11.2020Receipt of the translation of the claim(s)
Divisional application(s)EP20211902.0  / EP3901274
Opposition(s)17.09.2021No opposition filed within time limit [2021/47]
Fees paidRenewal fee
23.08.2017Renewal fee patent year 03
23.08.2018Renewal fee patent year 04
20.08.2019Renewal fee patent year 05
19.08.2020Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL16.12.2020
[2021/45]
Documents cited:Search[Y]WO2009066919  (KOREA RES INST OF BIOSCIENCE [KR], et al) [Y] 1-15 * the whole document *;
 [Y]  - "SubName: Full=UDP-N-acetylglucosamine--dolichyl-phosphate N-acetylglucosaminephosphotransferase {ECO:0000313|EMBL:EGV99104.1};", UniProt, (20111116), Database accession no. G3I967, URL: EBI, XP002778294 [Y] 1-15 * the whole document *
 [Y]  - SCOCCA J R AND KRAG S S, "Sequence of a cDNA that specifies the uridine diphosphate N-acetyl-D-glucosamine:dolichyl phosphate N-acetylglucosamine-1-phosphate transferase from chinese hamster", JOURNAL OF BIOLOGICAL CHEMISTRY, AMERICAN SOCIETY FOR BIOCHEMISTRY AND MOLECULAR BIOLOGY, (19901125), vol. 265, no. 33, ISSN 0021-9258, pages 20621 - 20626, XP002145333 [Y] 1-15 * page 20621 *
International search[XY]US2009162900  (ENENKEL BARBARA [DE], et al) [X] 1-3, 22, 26 * claim 1, 2, 13; para [0038], para [0085], Table 1,>]; para [0083] * [Y] 5, 23-25, 27, 41-46;
    [ ] - "Human N-acetylglucosaminyltransferase I (GtcNAc- TI) mRNA", GenBank, (19940000), Database accession no. M55621.1
 [Y]  - SCOCCA et al., "Sequence of a cDNA That Specifies the Uridine Diphosphate IV-Acetylo- glucosamine:Dolichol Phosphate N- Acetylglucosamine-1-phosphate Transferase from Chinese Hamster Ovary Cells.", JBC, (19900000), vol. 265, no. 33, pages 20621 - 20626, XP002145333 [Y] 5, 23-25, 27, 41-46 * ; Abstract; pg 20621; GenBank: M36899.1. Hamster uridine diphosphate N-acetyl D-glucosamine dolichol phosphate N-acetyl-glucosamine-1 phosphate transferase mRNA. transferase (27 April 1993) [Retrieved from the Internet 02 October 2015: ] *
by applicantUS4634665
 US4656134
 US5589466
 US5973972
 US5972650
 US6077835
 WO0070087
 US7435553
 WO2009066919
 US2009162901
 US2010291626
    - SOCCAKRAG, J. Biol. Chem., (19900000), vol. 265, no. 33, pages 20621 - 20626
    - CUMMING, D.A., Glycobiology, (19900000), vol. 1, no. 2, pages 115 - 130
    - BREYER, D. et al., Critical Reviews in Plant Sciences, (20140000), vol. 33, pages 286 - 330
    - KERSHAW, M.H. et al., Nature Reviews: Cancer, (20130000), vol. 13, pages 525 - 541
    - EAKER et al., Stem cells Trans. Med., SCTMEXPRESS, (20131007), vol. 2, pages 871 - 883
    - KING, I.A.TABIOWO, A., "Effect of tunicamycin on epidermal glycoprotein and glycosaminoglycan synthesis in vitro", Biochem. J., (19810000), vol. 198, no. 2, pages 331 - 338
    - KOIZUMI et al., Plant Physiol., (19990000), vol. 121, no. 2, pages 353 - 362
    - CRISCUOLOKRAG, J Biol Chem, (19820000), vol. 263, no. 36, pages 19796 - 19803
    - KOIZUMI et al., Plant Physiology, (19990000), vol. 121, pages 353 - 361
    - SCOCCAKRAG, J Biol Chem, (19900000), vol. 265, no. 33, pages 20621 - 20626
    - LEHRMAN, M. et al., J Biol Chem, (19880000), vol. 263, no. 36, pages 19796 - 803
    - SCOCCA JR et al., Glycobiology, (19950000), vol. 5, no. 1, pages 129 - 36
    - CRICK, D.C. et al., J Biol Chem, (19940000), vol. 269, no. 14, pages 10559 - 65
    - BORK, K. et al., J Pharm Sci., (20090000), vol. 98, no. 10, pages 3499 - 3508
    - SYKESJOHNSTON, Nat Biotech, (19970000), vol. 12, pages 355 - 59
    - BOCH J et al., Science, (20090000), vol. 326, pages 1509 - 1512
    - STELLA, S. et al., Acta Cryst., (20140000), vol. D70, pages 2042 - 2052
    - GOSSEN et al., Proc. Nat. Acad. Sci. USA, (19950000), vol. 89, pages 5547 - 5551
    - FIERS et al., Nature, (19780000), vol. 273, page 113
    - KIM S. K.WOLD B. J., Cell, (19850000), vol. 42, page 129
    - GRANT et al., Methods in Enzymol, (19870000), vol. 153, pages 516 - 544
    - DYMECKI, S., PNAS, (19960000), vol. 93, no. 12, pages 6191 - 6196
    - FEIL et al., Biochem. Biophys. Res. Commun., (19970000), vol. 237, pages 752 - 757
    - ARAKI et al., PNAS, (19950000), vol. 92, pages 160 - 4
    - NAGY, A. et al., Genesis, (20000000), vol. 26, pages 99 - 109
    - ARAKI et al., Nuc Acids Res, (20020000), vol. 30, no. 19, page e103
    - RON DWALTER P, Nat Rev Mol Cell Biol., (20070000), vol. 8, pages 519 - 529
    - GLUZMAN, Cell, (19810000), vol. 23, page 175
    - KAUFMAN, Meth. Enzymology, (19880000), vol. 185, page 537
    - ANUMULADHUME, Glycobiology, (19980000), vol. 8, no. 7, pages 685 - 694
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.